Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yea surprised it didn't meet either wndpoint in any significant way. Thought for sure we would get at least a .5-.7% decrease in A1c. Well it's gonna be brutal guys.
It has been located in every quarterly and yearly financial report since 2019 or 2020. HTIT disputes terms of the agreement, and something like $5m of what's been received already is held in a special account pending any hopeful future resolution of the agreement. No updates on any resolution has been made in the 3 years though. At this point, China market really should be seen as a liability. The S. Korean deal is better in ways, however even that isn't with a large, established partner
Nobody addresses the fact that we've had a disagreement with HTIT with no milestone payments for years, while the company stated we should expect China results before US trials, yet we still don't have any. Chances are, something is going on in China
I don't think we are close to a breakthrough and penetrating the injectable vaccine market. Oravax failed to even get a major trial approved in Israel (home country of Oramed), South Africia or anywhere as promised. Early results from the COUPLE of people they were finally able to administer it to showed okay results but nothing that would lead the world to transitioning over to pill form. It's definitely an oral insulin play company for the foreseeable future. Just becareful buying into the hype some people will try to sell you. Is there a potential large market here? Absolutely. Is this a "sure bet" or likely gonna increase 10X over the next year? Absolutely not. But hey I have plenty of shares and would love to be proved wrong on that count.
There are a lot of people with unrealistic expectations of what could happen with positive phase 3 topline data. Realistically, January will bring top line data from the first of two phase 3 trials. If they're how we hope, I think we could see an increase back in the high teens or low 20s. More important will be conclusion of both phase 3 trials and eventual sales from BLA approval by FDA. Sales would be needed or regulatory approval with solid licensing deals in other markets before this thing would really take off. Any idea of 50-100 SP before 2025 or late 2024 is delusional.
There is an absolute difference between the results from our company and theirs. If you look at the statistical data presented, they have results that could possibly even push FDA to give emergency use after starting a phase 3. We don't have any data to indicate how well we met the secondary endpoint of the trial. When those numbers are released, we can compare Apple to apples with their numbers. I doubt we will reproduce their numbers however we are focusing on patients with NASH and T2D which I don't believe they were. So we do have different markets possibly between us.
Literally nobody cares
This chart guy might be the worst chart maker ever. Yes, of course a biotech stock up 200% and counting over a week will have a major pullback sooner or later. But he obviously has no idea when it will be.
Yea I don't expect this to be a quick mover myself back to being able to trade. It seems like the company has dumped more than enough resources into removing the CE status that I do believe it will happen first half of 2022. But definitely will take some time to be current. If I could buy these 0002-0003 shares, I definitely would
The company has tried swinging momentum back now for over a month. They definitely would have announced if the trial started. I'm not sure what the current excuse they're on for not starting trials (we are over 6 months delayed now) but obviously the market has taken this into account and PPS has been affected accordingly. If trials don't start soon, there will not be time to bring to market an effective and profitable vaccine.
I do agree abandoning the trial would be a terrible decision for the company. Then again, the trial was supposed to start in June 21, Oct 21, approval in Israel in Oct 21 and was "approved" in S. Africa in November with a grand total of 1 enrolled in that trial so far. The COVID pill has been nothing short of an unmitigated disaster to date.
I think it is another great source of revenue for the company to continue pursuing use if the enzyme products. I'm actually surprised the volume isn't even higher today than it is. I know US investors can't buy in but would figure those outside US would load up. I picked up 4mil more last year before it shut down trading and would love to get some more in the .000's when they become current
I mean aren't we only at animal testing so far also? Nothing released by the company indicates they have progressed in S. Africa to the point of finding the 24 volunteers or administering the pills yet there?
I still see ORMPs major market for thr COVID pill being developing nations which probably wouldn't have as easy access to treatment like this. Robust antibody/immunity results from phase one human trials with our 3 spike protein in a pill would still do a lot for the stock. Obviously still here for oral insulin but worst case scenario COVID pill has left us well funded (think I saw around 180 million in cash after $50 million stock offering this week) to get through phase 3 trials with 0801 and other phase 2 trials (hopefully phase 3 in future)
Pretty sure last I saw they were sitting on around 110 million and that was before the 100 million offering at the market was utilized much. Phase 3 trials are expensive especially with over 1,000 people between the two trials but seems like they should definitely be fully funded by now. Will be interested to see how much cash on hand they have come quarterly financials.
Additionally, ORMP's pill uses human insulin which is roughly 10x cheaper than what other pills have attempted in the past. Nadav has mentioned how the pill would be equivalent or cheaper than injectable insulin.
COVID vaccine trials have been taking a suspiciously long time to receive approval from the ministry of health. Original target date was June 2021 however we are almost in October without approved trials. Stock price holding well without, but they will need to deliver on that front soon to keep momentum going.
If this page is good for anything, it is the minute to minute uodate of how much Fmello has made that day :) well I obviously wish I bought more in the 2s but consider myself tapped out with a little over 5,400 shares
I read somewhere the meetings where the approval would be determined happen biweekly with the ministry of health. Based on that timeline, we should be looking at this week, next at absolute worst. I heard the stock rose on the Israeli market today but wouldn't be surprised if some profits are taken or shorts move on this early next week if buying pressure eases up, but fully expect to see the 20s when final approval is issued. Will add some more if a dip happens Monday/Tuesday bringing it down in the low 16s. If not, I'm vested already with a comfortable share count and ready for the ride to continue
I agree. While I am not excited about possibility of dilution up to $250 million worth of common shares, I do believe their intentions are to offer these at higher levels when positive phase 1 results are achieved, or maybe before results are released and we have a larger stock increase on anticipation of results. This could fund many trials through phase 3 along with research and development of Oravax creating new vaccine pills. Hopefully they don't dilute a bunch at these levels and I will watch closely each quarter financial statement to see how much was sold on the open market. But optimistic this means they expect much higher stock price to take advantage of coming up.
I do agree that is way too much dilution, however they are not increasing outstanding shares to 250million but authorized to sell up to 250 million worth of stock on the open market. What will hopefully be around 10-15 million ish shares over time if positive results from COVID pill increase stock price. At most this would dilute us around 20 million shares.
I hope their thoughts are "let's have a huge offering available to us for when we increase greatly in stock price from successful trials so we can sell shares at $50-75 per stock and fund all future trials" but who knows the price point they plan on selling these at. The one good thing is so much of the boards compensation is in the form of stock so they need the stock price to rise for them to be able to cash in long term also.
So it appears they modified their previously approved common stock offering to allow up to $250 million worth to be sold. They previously were approved for up to $100 million but I think the SEC just approved this one today which is why it was just released.
Sucks because obviously the company is looking to cash in on trials when they are taking place for the COVID pill. And selling 100-250 million worth of shares on the open market will obviously lower the amount the stock can increase with positive phase 1 results. Still think it is a good sign overall as the company believes there will be a large amount of volume and price increase to support selling shares.
I lost $14k today and thought that was a lot! Lol nothing like a $50k day. Overall I think we recover pretty quick when ministry of health approves the trials to officially start. I actually bought a little more today on the dip in the upper 13s
Have a link to the article by chance? Thought they only had an offering available to offer 100 million worth of shares currently.
They've been saying trials are pending for 4 months now with no update, and today changed their offering to be able to sell up to $100 million worth of shares. Unless COVID news drops soon, this gonna be a bumpy ride
I do not have the answer to that one. I would expect nobody involved with this had any history with EESO back in the day. It would draw too much attention I'd think, especially if they were complacent in everything that occurred back then.
If anything I believe it was genius to pick this shell. I mean think about, it has a history of going from 000X to penny land. I've seen multiple times on here or StockTwits how people mentioned it has a history of taking off. That adds to the lore and FOMO factor people would have about it taking off again.
Oh I am definitely highly skeptical about what is going on here after a decade of death. So the reason someone like Ice Storm comes in and buys what is called a "shell" I believe is because it is much cheaper than filing for your own ticker. Now the reason I would dump a couple more k in this if I could buy at 0001 is because Ice Storm has paid a significant amount of money just to purchase the shell, get current with SOS and begin the process of beconing current. They didn't do all this without a long term plan to market the company and in turn make them money. So even though my 4 million shares have an average of 0006-0007, I am fine with the position as long as we get the CE removed.
No it's not. I just attempted another 1.5 million order and same "cannot execute orders as we don't trade CE stocks" message came up. Not freely trading if you can't execute a buy order. This will take off again if or when CE is removed. Until then, low volume... And yes 15 million shares at 0001 is low volume lol. Unless you think 1500 is big money
15 million is $1,500 dollars. Before the CE status was implemented this was doing $100,000 plus in trades on many trading days. $1,500 wpuld indicate this still isn't being traded in the US. Other countries have platforms available for people to trade still
Are you based in the US? Because I just tried to place another one and they give the same message when I hit submit where they're not accepting orders on CE stocks at this time.
Everyone usually has the earnings date wrong on this one for some reason. I remember the company usually releases like something the day before maybe to say earnings is actually coming? Might be wrong but I do remember it drops on a random day usually.
TDA is not accepting trades of this. I just tried placing an order again and they will not allow it to go through with the CE status
They have a current offering at the market however this was not those shares. And there was absolutely 3 million shares sold. Of course that also means there was 3 million buy orders in to purchase those shares
That is interesting and I definitely don't have experience with additions or removal from the Russell. But still odd the volume started about 10 minutes before close. Also seems odd that we would be added and all that volume would come in as sells instead of buying. But there is much I don't understand about stocks so that is probably it lol. Should have some clarity on Monday
Don't understand how inclusion in the Russell on Monday would lead to a sell off of 3 million plus shares but would love to hear it!
I figured there would have been more info on ut out here. Insider selling shares? I mean this shouldn't have been technical trading as we were trading in a tight range up for the day previous to it. Definitely a little concerning having 3 plus million shares sold in the last 10 minutes and after hours trading.
Dang, lucky you! I'd add a bunch more down here if I could still trade it on TD Ameritrade
The way I read the SEC release, I interrupted it as the shares could be sold at the market which is just a regular offering or to other institutional owners. I didn't see anything in the actual SEC report that says before news is released in July. I did see on StockTwits someone mentioned news in July but like nothing backing that up. Did you see something else I'm missing?
Wish I could trade this right now on TDA also. What platform you use to buy?
Where you trading these shares on?
Lol no, I was busy at work and didn't even get a call into TDA today. Will one day soon. I wish this was the beginning of something but it looks like total volume was only 3.X million so likely just a blip on the radar. Do believe we will see some major buying once that CE is removed... Just wish I had a rough estimate of how long that can take